Invizius

A community research laboratory site

Largest kinetic biomarker expression study on Haemodialysis patients

Invizius and Manchester University NHS Foundation Trust are conducting, with EMS Healthcare's support, the largest kinetic biomarker expression study on Haemodialysis patients anywhere in the world.

The lab enables the clinical team to rapidly process and cryopreserve the blood samples of over 600 volunteers. This enables “immune snapshots” to be taken from dialysis patients for the first time.

EMS Healthcare's team of technicians drive the lab to various hospitals across North-West England, liaising with clinical staff to ensure fragile immune biomarkers are processed.

Tailor-made for every partner’s unique set of challenges

This groundbreaking project with Invizius faced a unique set of challenges that the collaboration is designed to overcome – delivering a compelling example of a successful public/private partnership.

At the Manchester Foundation Trust Satellite Dialysis Unit based in Tameside, EMS Healthcare's clinical technicians process bloods from dialysis patients. The samples are then taken back to EMS Healthcare's HQ in Cheshire on board the laboratory. Here, they are stored at minus 80 degrees Celsius, before being sent on to a laboratory in Glasgow for biomarker analysis.

Due to the technical challenges, no-one had ever conducted a kinetic study over the time course of dialysis and the mobile solution enables a “world first” insight into the dialysis inflammation status of patients.